×
Pieris Pharmaceuticals Share Holder Equity 2014-2024 | PVLA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Pieris Pharmaceuticals share holder equity from 2014 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
View More
Pieris Pharmaceuticals Share Holder Equity 2014-2024 | PVLA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Pieris Pharmaceuticals share holder equity from 2014 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
NPK (NPKI)
$626M
Performant Healthcare (PHLT)
$245M
FTAC Emerald Acquisition (FLDD)
$158M
Swiftmerge Acquisition (ANNA)
$42M
Insight Acquisition (AMOD)
$23M
Hanryu Holdings (GITS)
$17M
LQR House (YHC)
$11M
ATIF Holdings (ZBAI)
$9M
Lion Electric (LEVGQ)
$0M